| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.01 |